Clinical use of Hypericum perforatum (St John’s wort) in depression: A meta-analysis
CNP Research Summary can be found in the CNP Library Membership
The CNP Herbs and Mental Health Research Category consolidates research exploring the application of herbs in psychological and psychiatric health. Jill Troderman is CNP's Herbs and Mental Health contributor and is the lead developer of this research category. To view each original study on the open internet, click “Original.” To view the CNP-written abstract summary, click “CNP Summary.” While only some of the CNP-written abstract summaries are available below for free, all abstract summaries are available to CNP members through the CNP Library Membership.
While there have been studies investigating the adaptogenic herb ashwagandha and its use in combating stress, Salve et al. (2019) claim this study to be the first to offer insight into the dose-response of a high concentration root extract. This double-blind study included 60 participants (male and female), with a baseline perceived stress scale (PSS) score greater than 20. The participants were randomly selected to receive capsules of 125 mg of ashwagandha extract, 300 mg of ashwagandha extract, or an identical placebo twice daily for eight weeks in a 1:1:1 ratio. The following measures were taken: stress (using PSS) at baseline, at four weeks and eight weeks; anxiety using the Hamilton-Anxiety (HAM-A) scale; cortisol levels in the blood at baseline and at eight weeks; and sleep quality utilizing a seven-point sleep scale. Fifty eight of the 60 participants completed the study (96.7% completion rate). Both a significant reduction in PSS scores and a drop in cortisol levels were seen in participants who took 250 mg/day or 300 mg/day of ashwagandha extract. Moreover, sleep quality was significantly better in those that received ashwagandha relative to the placebo group. These findings show that the ashwagandha root aqueous extract may have stress and anxiety-relieving properties. [NPID: adaptogens, herbs, ashwagandha, stress, anxiety, cortisol]
Clinical use of Hypericum perforatum (St John’s wort) in depression: A meta-analysis
CNP Research Summary can be found in the CNP Library Membership
Dietary intake of the citrus flavonoid hesperidin affects stress-resilience and brain kynurenine levels in a subchronic and mild social defeat stress model in mice (animal)
A double-blind, randomized pilot study for comparison of Melissa officinalis L. and Lavandula angustifolia Mill. with Fluoxetine for the treatment of depression
Effects of Gladiolus dalenii on the stress-induced behavioral, neurochemical, and reproductive changes in rats (animal)
CNP Research Summary can be found in the CNP Library Membership
Cannabidiol: A potential new alternative for the treatment of anxiety, depression, and psychotic disorders
Role of 5-HT1A receptor in the anxiolytic-relaxant effects of bergamot essential oil in rodent (animal)
Assessment of Withania somnifera root extract efficacy in patients with generalized anxiety disorder: A randomized double-blind placebo-controlled trial
Use of complementary alternative medicine and the associated factors among patients with depression
CNP Research Summary can be found in the CNP Library Membership
Cannabidiol as a therapeutic alternative for post-traumatic stress disorder: From bench research to confirmation in human trials